These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28716290)

  • 1. Yarsagumba Fungus: Health Problems in the Himalayan Gold Rush.
    Koirala P; Pandit B; Phuyal P; Zafren K
    Wilderness Environ Med; 2017 Sep; 28(3):267-270. PubMed ID: 28716290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High altitude organic gold: The production network for Ophiocordyceps sinensis from far-western Nepal.
    Pouliot M; Pyakurel D; Smith-Hall C
    J Ethnopharmacol; 2018 May; 218():59-68. PubMed ID: 29474899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Newly Constructed Motor Vehicle Road on Altitude Illness in the Nepal Himalayas.
    Reisman J; Deonarain D; Basnyat B
    Wilderness Environ Med; 2017 Dec; 28(4):332-338. PubMed ID: 28781177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illness and injury to students on a school excursion to Peru.
    Shaw MT; Harding E; Leggat PA
    J Travel Med; 2014; 21(3):183-8. PubMed ID: 24612303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Work-health needs of high-altitude mountain guides (Sherpas) in Nepal - a pilot study.
    Macdonald EB; Shrestha S; Chhetri MK; Sherpa LR; Sherpa da G; Murray K; Sanati KA
    Int J Occup Saf Ergon; 2015; 21(1):9-14. PubMed ID: 26327257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Prospective Observational Study on Mountaineering Emergencies in Western Alps: Mind Your Head.
    Brustia R; Enrione G; Catuzzo B; Cavoretto L; Pesenti Campagnoni M; Visetti E; Cauchy E; Ziegler S; Giardini G
    High Alt Med Biol; 2016 Jun; 17(2):116-21. PubMed ID: 27213694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Altitude Illness: Knowledge, Practice, and Attitudes of Porters in Nepal.
    Koirala P; Wolpin SE; Peterson JT
    Wilderness Environ Med; 2018 Dec; 29(4):431-436. PubMed ID: 30292563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older age, chronic medical conditions and polypharmacy in Himalayan trekkers in Nepal: an epidemiologic survey and case series.
    Keyes LE; Mather L; Duke C; Regmi N; Phelan B; Pant S; Starling J; McElwee M; Cole D; McConnell T; Paudel P; Sallade TD; Sheets A; Twillman D; Young DS; Basnyat B
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mt Everest Base Camp Medical Clinic "Everest ER": epidemiology of medical events during the first 10 years of operation.
    Némethy M; Pressman AB; Freer L; McIntosh SE
    Wilderness Environ Med; 2015 Mar; 26(1):4-10. PubMed ID: 25435349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational health of miners at altitude: adverse health effects, toxic exposures, pre-placement screening, acclimatization, and worker surveillance.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2011 Aug; 49(7):629-40. PubMed ID: 21861588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms of infection and altitude illness among hikers in the Mount Everest region of Nepal.
    Murdoch DR
    Aviat Space Environ Med; 1995 Feb; 66(2):148-51. PubMed ID: 7726779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L; Sherpa C; Nickol A; Windsor J
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin levels in a Himalayan high altitude population.
    Beall CM; Reichsman AB
    Am J Phys Anthropol; 1984 Mar; 63(3):301-6. PubMed ID: 6731601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding of Altitude Illness and Use of Pharmacotherapy Among Trekkers and Porters in the Annapurna Region of Nepal.
    Havryliuk T; Acharya B; Caruso E; Cushing T
    High Alt Med Biol; 2015 Sep; 16(3):236-43. PubMed ID: 26244262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to moderate altitude and cardiorespiratory diseases.
    Gong H
    Cardiologia; 1995 Jul; 40(7):477-88. PubMed ID: 8529252
    [No Abstract]   [Full Text] [Related]  

  • 16. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up.
    Gaillard S; Dellasanta P; Loutan L; Kayser B
    High Alt Med Biol; 2004; 5(4):410-9. PubMed ID: 15671630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and psychological illness symptoms at high altitude and their relationship with acute mountain sickness: a prospective cohort study.
    Oliver SJ; Sanders SJ; Williams CJ; Smith ZA; Lloyd-Davies E; Roberts R; Arthur C; Hardy L; Macdonald JH
    J Travel Med; 2012 Jul; 19(4):210-9. PubMed ID: 22776381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of patients with severe altitude illness in Nepal.
    Leshem E; Pandey P; Shlim DR; Hiramatsu K; Sidi Y; Schwartz E
    J Travel Med; 2008; 15(5):315-22. PubMed ID: 19006504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
    McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B
    Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.